Last week, readers were most interested in a story about Pfizer shuttering the Lucira Health business that it acquired in 2023.

Qiagen alleges that BioMérieux infringes a European patent that protects the company's QuantiFeron interferon-gamma release assay technology for latent TB detection.

Of the 30 companies on the list, 22 firms saw their share prices decline month over month, while eight companies saw their stock prices rise.

The firm's Anti-Measles Virus ELISA 2.0 (IgG) is used with dried blood spot samples to identify infections and determine patients' immune status.

The paper-based card separates plasma from whole-blood samples, allowing them to be used for HIV viral load testing.

NEW YORK — Dutch diagnostics firm MRC Holland said on Friday that two of its blood-based assays for spinal muscular atrophy (SMA) have been certified under Europe's In Vitro Diagnostic Regulation ...

The group recently published a case-control study showing high sensitivity and specificity, with little drop in early-stage disease, compared to late-stage cancer.

The company aims to soon launch two tests to aid the treatment of dermatomycosis and is developing other tests for healthcare ...

The firm's Qlucore Diagnostics 1.0 for BCP-ALL software is used to aid the diagnosis and treatment of B-cell precursor acute lymphoblastic leukemia.

While electronic exchange of orders and results is commonplace in the commercial lab world, public health labs struggle with inconsistent levels of connectivity.

NEW YORK – The International Alliance for Cancer Early Detection (ACED) recently received £50 million ($63 million) to continue its efforts to develop new approaches for detecting cancer earlier in ...